Drug and therapeutics committees: a Swedish experience.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
Works matching IS 10109609 AND DT 2002 AND VI 16 AND IP 3
Results: 37
1
2
International Nonproprietary Names for Pharmaceutical Substances (INN).
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 243
- Publication type:
- Article
3
Good storage practices.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 242
- Publication type:
- Article
4
Dialogue in pharmacovigilance.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 242
- Publication type:
- Article
5
Effective drug regulation.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 242
- Publication type:
- Article
6
The Importance of Pharmacovigilance.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 241
- Publication type:
- Article
7
Surveying and Evaluating Ethical Review Practices.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 241
- Publication type:
- Article
8
International Ethical Guidelines for Biomedical Research Involving Human Subjects.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 241
- Publication type:
- Article
9
The future of ATC/DDD and drug utilization research.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 238
- By:
- Publication type:
- Article
10
Drug utilization data constraints in developing countries.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 237
- By:
- Publication type:
- Article
11
Trends in drug utilization research in developing countries.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 236
- By:
- Publication type:
- Article
12
Drug utilization statistics and health policy.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 235
- By:
- Publication type:
- Article
13
A historical overview of the ATC/DDD methodology.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 233
- By:
- Publication type:
- Article
14
Ezetimibe approved for cholesterol-lowering.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 232
- Publication type:
- Article
15
Re-introduction of urokinase.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 232
- Publication type:
- Article
16
Inhaled corticosteroids and adrenal suppression.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 231
- Publication type:
- Article
17
Sertraline interactions.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 231
- Publication type:
- Article
18
Acetylsalicylic acid and Reye's syndrome.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 230
- Publication type:
- Article
19
Ergotamine and ischaemia.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 230
- Publication type:
- Article
20
Oxaliplatin for colorectal cancer.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 230
- Publication type:
- Article
21
Generic omeprazole approved.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 229
- Publication type:
- Article
22
Glucowatch for diabetes.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 229
- Publication type:
- Article
23
Mefloquine labelling strengthened.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 228
- Publication type:
- Article
24
Parecoxib/valdecoxib: serious hypersensitivity reactions.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 228
- Publication type:
- Article
25
Valdecoxib: new warnings.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 228
- Publication type:
- Article
26
Lepirudin and fatal anaphylactic reactions.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 227
- Publication type:
- Article
27
Human tissue recalled.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 227
- Publication type:
- Article
28
Buprenorphine approved for opiate dependence.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 227
- Publication type:
- Article
29
Ergot-derived dopamine receptor agonists: fibrotic reactions.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 226
- Publication type:
- Article
30
Epoetin alfa: pure red cell aplasia.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 226
- Publication type:
- Article
31
Indapamide and hyponatraemia.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 225
- Publication type:
- Article
32
Herbal mixture and palpitations.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 224
- By:
- Publication type:
- Article
33
Leflunomide: haematologic, hepatic and respiratory reactions.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 223
- By:
- Publication type:
- Article
34
Adverse reactions to natural health products.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 222
- By:
- Publication type:
- Article
35
The Parenteral Society.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 220
- Publication type:
- Article
36
Tenth International Conference of Drug Regulatory Authorities.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 214
- Publication type:
- Article
37
Drug and therapeutics committees: a Swedish experience.
- Published in:
- WHO Drug Information, 2002, v. 16, n. 3, p. 207
- Publication type:
- Article